Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria
Oxyact 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Middle blue, vaulted, oblong film-coated tablets with break score on both sides. The tablet can be divided into equal halves. Diameter: 10.1 mm |
Each film-coated tablet contains 10 mg oxycodone hydrochloride equivalent to 8.97 mg oxycodone.
Excipients with known effect: Each film-coated tablet contains 64.48 mg lactose (as monohydrate) and 0.21 mg soya lecithin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Oxycodone |
Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative. |
| List of Excipients |
|---|
|
Tablet core: Sodium starch glycolate type A Tablet coating: Polyvinyl alcohol |
Child resistant PVC/PVdC/aluminium blisters containing 10, 20, 30, 56 and 60, film-coated tablets.
Not all pack sizes may be marketed.
G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria
PL 21597/0042
11/10/2018
| Drug | Countries | |
|---|---|---|
| OXYACT | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
